EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Take-Home Naloxone for People who use Opioids: A Contribution to Reducing Drug-Related Deaths – Current Situation in Germany

Simon Fleißner, Heino Stöver, Dirk Schäffer, Heike Wodarz-von Essen, Daniel Deimel, Norbert Wodarz

SUCHT · 2026-04 · 72 (2) · 91-97

DOI: 10.1024/0939-5911/a000970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SUCHT, 2026-04. Verfasst von Simon Fleißner und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-related deaths associated with opioids are the leading cause of death related to illicit substances. Take-Home Naloxone (THN) as a nasal spray for people who use opioids (PWUO) could prevent fatalities. However, it has not yet been widely implemented in Germany. This article consolidates findings from the two pilot projects, BayTHN and NALtrain, to provide an overview of THN in Germany and formulates recommendations for its broader implementation.

Method

Since 2018 within two observational studies, initially with BayTHN and additionally with NALtrain from 2021 onwards, PWUO have received standardized overdose education followed by access to THN.

Results

Across both projects, 1020 staff members were trained to provide THN. With additionally 595 PWUO documented by the Bavarian State Ministry of Health, Care and Prevention (StMGP) at least 2,664 PWUO were reached with THN (1.6 % of PWUO in Germany), and 203 THN administrations were documented.

Conclusion

For THN to reach its full harm reduction potential, at least 30 % of PWUO (50,000 PWUO) should be reached. THN has already been successfully implemented in various settings in Germany, but not nationwide. The reluctance of physicians to prescribe THN and the lack of funding for overdose education and THN in most federal states remain key barriers to a broader implementation.

Zitieren

APA

Fleißner, S., Stöver, H., Schäffer, D., Essen, H. W., Deimel, D., & Wodarz, N. (2026). Take-Home Naloxone for People who use Opioids: A Contribution to Reducing Drug-Related Deaths – Current Situation in Germany. SUCHT, 72(2), 91-97. https://doi.org/10.1024/0939-5911/a000970

Vancouver

Fleißner S, Stöver H, Schäffer D, Essen HW, Deimel D, Wodarz N. Take-Home Naloxone for People who use Opioids: A Contribution to Reducing Drug-Related Deaths – Current Situation in Germany. SUCHT. 2026;72(2):91-97. doi:10.1024/0939-5911/a000970

BibTeX
@article{Fleiner2026,
  author = {Fleißner, Simon and Stöver, Heino and Schäffer, Dirk and Essen, Heike Wodarz-von and Deimel, Daniel and Wodarz, Norbert},
  title = {Take-Home Naloxone for People who use Opioids: A Contribution to Reducing Drug-Related Deaths – Current Situation in Germany},
  journal = {SUCHT},
  year = {2026},
  volume = {72},
  number = {2},
  pages = {91--97},
  doi = {10.1024/0939-5911/a000970}
}
Kostenlos starten →